Answers are grounded in this paper and cite their sources.
There has been considerable interest in the development of new anti tubercular agents particularly against multidrug resistance and extensively drug resistant strain of tuberculosis because mycobacterium species have developed resistant against currently used drugs. The currently use antitubercular drugs having toxic effect and long period of therapeutic treatment. Therefore, many researchers have synthesized various newer drugs and analogues of currently used drugs for tuberculosis treatment. These observations have been guiding for the development of newer analogues that possess potent antitubercular activity with minimum side effects with effectiveness against multidrug resistant mycobacterium , and also in patient co-infected with HIV/AIDS. In this review we are discussed about isoniazid and it analogues as potent antitubercular agents.
No takes yet. Share an insight, caveat, or question.
Mohammad Asif (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: